GRAPHTX

GraphTx

@graphtx

Vienna
http://graphtx.com
Biotechnology Research

Overview

About GraphTx

Graph is a precision immunology techbio that leverages perturbation modeling from primary patient cell samples combined with multi-omics data to deliver transformative targeted therapies and biomarkers for immune-driven diseases. Graph believes that due to an incomplete understanding of complex immune-mediated diseases, millions of patients are left without adequate treatment options - and AI trained with complex disease data can solve this.

Headquarters

Vienna

Website

http://graphtx.com

Company Size

11-50 employees

Industry

Biotechnology Research

Company Type

Privately Held

Founded

2024

Specialties

-

Jobs

Posts